Immune functional testing in clinics: Feasibility and prediction of deleterious outcomes

Critical Care Medicine

Volumn 41, Issue 1, 2013, Pages 367-368

  Monneret, Guillaume ^a,b   Venet, Fabienne ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

immunosuppression; lymphocyte; nosocomial infections; sepsis; trauma

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; BRAIN INJURY; EDITORIAL; GRANULOMA; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; INTENSIVE CARE UNIT; LYMPHOCYTE PROLIFERATION; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL;

BRAIN INJURIES; FEMALE; GRANULOMA; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MYCOBACTERIUM BOVIS; PNEUMONIA, VENTILATOR-ASSOCIATED; SUBARACHNOID HEMORRHAGE;

EID: 84872063504     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318270e6a6     Document Type: Editorial

References (12)

1. Safdar N, Dezfulian C, Collard HR, et al: Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med 2005; 33:2184-2193
2. Kethireddy S, Kumar A: Mortality due to septic shock following early, appropriate antibiotic therapy: Can we do better?. Crit Care Med 2012; 40:2228-2229
3. Hotchkiss RS, Coopersmith CM, McDunn JE, et al: The sepsis seesaw: Tilting toward immunosuppression. Nat Med 2009; 15:496-497
4. Pugin J: Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp 2007; 280:21-27; discussion 27
5. Monneret G, Venet F, Kullberg BJ, et al: ICU-acquired immunosuppression and the risk for secondary fungal infections. Med Mycol 2011; 49(Suppl 1):S17-S23
6. Monneret G, Venet F, Pachot A, et al: Monitoring immune dysfunctions in the septic patient: A new skin for the old ceremony. Mol Med 2008; 14: 64-78
7. Deknuydt F, Roquilly A, Cinotti R, et al: An In Vitro Model of Mycobacterial Granuloma to Investigate the Immune Response in Brain-Injured Patients. Crit Care Med 2013; 41:245-254
8. Meisel C, Meisel A: Suppressing immunosuppression after stroke. N Engl J Med 2011; 365:2134-2136
9. Puissegur MP, Botanch C, Duteyrat JL, et al: An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. Cell Microbiol 2004; 6: 423-433
10. Boomer JS, Shuherk-Shaffer J, Hotchkiss RS, et al: A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit Care 2012; 16:R112
11. Unsinger J, Burnham CA, McDonough J, et al: Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. J Infect Dis 2012; 206:606-616
12. Hotchkiss RS, Opal S: Immunotherapy for sepsis-a new approach against an ancient foe. N Engl J Med 2010; 363:87-89